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The  ability of cells  to  bind  immunoglobulin (Ig) and  immune complexes  is 
mediated by receptors that recognize the Fc portion of Ig. Fc receptors (FcR) 1 
have been described on subsets of most cell types of the immune system (reviewed 
in  1 and  2).  The  binding of immune complexes  to  FcR on  macrophages  and 
polymorphonuclear leukocytes triggers phagocytosis, cidal mechanisms, and the 
release of mediators of inflammation (3, 4). Several lines of evidence suggest that 
FcRs play a  role  in  regulation of the immune response.  Fc receptors  that are 
specific for each of the Ig isotypes have been reported (5-8) and, in several cases, 
isotype-specific FcR are induced on T  cells after administration of Ig (9-1 1). In 
addition,  soluble  Ig-binding factors  (IBF)  that  have  suppressive  or  enhancing 
activity on antibody responses have been described (12-14).  These factors may 
be related to Fc receptors described on cell membranes (15). 
The isolation of monoclonal antibodies directed against the Fc receptor specific 
for IgG2b and IgG1 aggregates (Fcv2b/v~R) (16) has led to the purification of the 
receptor (17) and the production of specific polyclonal anti-receptor sera.  The 
monoclonal and polyvalent anti-FC~2b/vlR antibodies have been used to develop 
a monoclonal sandwich radioimmunoassay with a sensitivity of ~ 1 fmol of Fc-r2b  / 
~IR (18).  In the studies reported here we have used this radioimmunoassay to 
study the expression of Fcvzb/v~R by murine spleen cells after polyclonal activation 
in vitro, the release of "soluble" Fc.r2b/vlR by iipopolysaccharide (LPS)-activated 
splenocytes, and the presence of Fc~2b/v~R-like material in mouse serum. 
Materials and methods 
Animals.  CD~F~, germ-free CD~, and their sex- and age-matched controls were ob- 
tained from Charles River Breeding Laboratories (Wilmington, MA). A/J, C57BL/6J, 
This work was supported by grants AI- 141603, AI-2131501, and CA-30198 from the U. S. Public 
Health Service. J. Unkeless is an American Cancer Society Research Scholar. E. Pure is supported 
by Damon Runyon-Walter Winchell Fellowship DRG-565. 
' Abbreviations used in this paper: BSA, bovine serum albumin; Con A, concanavalin A; FBS, fetal 
bovine serum; FcR, Fc receptor; FC~2b/vlR,  receptor for the Fc portion of IgG2b and IgG1; HBSS, 
Hanks' balanced salt solution; HSB, high-salt buffer; IBF, immunoglobulin-binding  factor; LPS, 
lipopolysaccharide; NP-40, Nonidet  P-40; PD,  Dulbecco's modified phosphate-buffered saline; 
RAMlg, rabbit anti-mouse lg; R1A, radioimmunoassay;  SDS, sodium dodecyl sulfate; SDS-PAGE, 
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B6A/J, BALB/c nu/nu and BALB/c nu/+ controls were from The Jackson Laboratories 
(Bar Harbor, ME). Swiss mice were from the Rockefeller University colony• 
Antibodies.  Affinity-purified rabbit antibodies against mouse Ig (RAMIg) and # (Ra#), 
and rat Ig were generously provided by Dr.  E. S.  Vitetta (University of Texas Health 
Science Center, Dallas,  TX). Affinity-purified rabbit anti-mouse 7  was purchased from 
Jackson ImmunoResearch Laboratories, Inc. (Avondale, PA). Two monocional anti-Thy- 
1.2 antibodies were used. Anti-Thy-l.2 (IgMk) is the product of the HO-13.4 hybridoma 
(19), and anti-Thy-l.2 (rat IgG) is the product of the HO-12.4 hybridoma. The rat anti- 
Lyt-1 (53.7.313) and anti-Lyt-2 (52.6.72) hybridomas (20) were obtained from Dr. E. S. 
Vitetta, and purified as previously .described (21). Monocional anti-Fc~b/~lR antibody, 
2.4G2, was purified from hybridoma ascites fluid by ion exchange chromatography on 
DE52 (Pharmacia Fine Chemicals, Piscataway, N  J). The papain Fab fragment was prepared 
as described (16) and purified on an LKB TSK 3000 column (LKB Produkter, Bromma, 
Sweden). A rabbit anti-Fc~b/~l R serum was prepared and adsorbed as described (18). 
Depletion ofT Cells.  T cells were removed by treatment of spleen cells with monoclonal 
anti-Thy-1.2 (HO-13.4) and baby rabbit serum as a source of complement (C) (PeI-Freez 
•  a 
Biologicals,  Rogers, AR). Alternatively, cells were treated with a cocktail of rat hybridoma 
antibodies directed against Thy-l.2 (HO-12.4), Lyt-1, and Lyt-2, followed by rabbit anti- 
mouse 3' chain and C. These treatments abolished the proliferative response to concana- 
valin A (Con A). 
Adherent Cell Depletion.  Adherent cells were depleted by passage of spleen cells twice 
through  Sephadex G-10.  Alternatively, splenocytes were allowed to adhere  to plastic 
tissue  culture dishes  for 2  h  at  37°C.  The nonadherent fraction was  replated for an 
additional 2 h after which the nonadherent cells were harvested by gentle pipetting. 
Depletion  of B Cells.  B cells were removed by panning on RAMIg-coated dishes (22) 
followed by passage through a  nylon wool column (23).  LPS-stimulated [SH]thymidine 
incorporation and Ig secretion of the depleted population was <5% that of the untreated 
control. 
Culture Conditions.  Spleen cells were cultured in 96-well microculture plates (Costar, 
Cambridge, MA) or 75-cm  2 flasks (Corning Glass Works, Corning, NY) at 0.5-1  x  106 
cells/ml in Hepes-buffered RPMI  1640 supplemented with penicillin (100 U/ml), strep- 
tomycin and gentamycin (10 #g/ml), 50 #M 2-mercaptoethanol, and 10% heat-inactivated 
fetal bovine serum (FBS) (KC Biological Inc., Lenexa, KS). Cultures were incubated in an 
atmosphere  of 7%  CO2  at  37°C.  Cells  were  stimulated  with  5  ~g/ml  Con  A  (Miles 
Laboratories, Inc., Elkhart, IN) or 20-50 #g/ml LPS (Salmonella  typhosa; Difco Labora- 
tories,  Inc.,  Detroit,  MI)  for  the  indicated  intervals•  Proliferation  was  measured  by 
incorporation of [SH]thymidine added during the last  16 h  of culture• J774  cells and 
$49.1 cells were grown in spinner cultures in Dulbecco's modified Eagle's medium plus 
5% FBS and a-minimum essential medium with 10% FBS, respectively. The BCL1 clone, 
CW 13.20-3B3 (CW 13.20), was generously provided by Drs. K. Brooks and E. S. Vitetta 
and maintained as described (24). 
Radioiodination  of Protein.  Protein (<50 #g) was  labeled with  1~5I as previously de- 
scribed (18).  However, iodinated FC~b/~R  was  separated  from free iodide by dialysis 
against Dulbecco's modified phosphate-buffered saline (PD). 
~5I-2.4G2-binding Assay.  Cells were washed by centrifugation in Hanks' balanced salt 
solution (HBSS) containing 1 mg/ml bovine serum albumin (HBSS/BSA). Cells (5-10 X 
l0  s) were then incubated for 1 h at 4°C with 0.5 #g/ml  ~sI-2.4G2 Fab (sp act, 5,000 
cpm/ng) in  100 #1 of HBSS/BSA. Cells were washed extensively in HBSS/BSA and the 
cell pellets were assayed for radioactivity. 
Radioimmunoassays (RIA).  Supernatants from cultures of stimulated cells were assayed 
for the presence of secreted IgM and IgG by a solid phase RIA as previously described 
(25).  FC~2b/~R present in whole cell Nonidet P-40 (NP-40) lysates,  culture supernatants, 
or serum was detected by a monoclonal sandwich RIA (18).  Briefly, aliquots of the cell- 
free supernatants, cell lysates, or serum were incubated with 1~5I-2.4G2 Fab (0.5 #g/ml, 
5,000 cpm/ng) in a total volume of 50 ~1 for 1 h  at room temperature. The resultant 
2.4G2  Fab-antigen  complexes were  immunoprecipitated with  either anti-FC~b/~lR  or 1838  SOLUBLE Fc  RECEPTORS 
normal  rabbit  serum  bound  to  heat-killed  formaldehyde-fixed Staphylococcus  aureus 
(Zymed Laboratories, Burlingame, CA). The bacteria were washed by centrifugation in 
PD containing 1% NP-40 and 0.2% sodium dodecyl sulfate (SDS) buffer, and the bacterial 
pellets were assayed for radioactivity. The relative amount of soluble FC,2b/,~R is expressed 
e-  ither by the amount of 12~I-2.4G2 Fab precipitated or in comparison with standards of 
J774 or $49.1  cell lysates, assuming 106 and 2 x  105 receptors per cell, respectively. 
Preparation  of Serum  and Plasma.  Mice  were anesthetized with ether and bled  by 
cardiac puncture. When plasma was prepared,  blood was collected in the presence of 
heparin. 
Affinity  Purification.  Circulating Fc~b/~R was affinity purified on 2.4G2 Fab-Sepha- 
rose 4B immunoadsorbent columns by passing serum three times through the column. 
The immunoadsorbent was then washed with  10  column volumes of PD,  I0  column 
volumes of a high-salt buffer (HSB)(0.6 M NaCI,  0.0125  M KPO4, pH 7.4, and 0.02% 
NaNa),  followed by 10 column volumes of a  mixed detergent solution (0.05%  NP-40, 
0.1% SDS, 0.3 M NaCI, and 10 mm Tris-HCl, pH 8.6), and again with 10 column volumes 
of HSB and  PD.  Bound material was then eluted with  1 M acetic acid, dialyzed into 
ammonium bicarbonate,  and  lyophilized. The  purified protein  was  iodinated by  the 
iodogen method (26) and analyzed by immunoprecipitation and SDS-polyacrylamide gel 
electrophoresis (SDS-PAGE). 
Immunoprecipitation.  Labeled protein  in  PD  was  precleared  by  incubation  with S. 
aureus precoated with normal rabbit serum. The unadsorbed protein was then mixed 
with normal rabbit- or rabbit anti-Fcv2b/r~R antibody-precoated, formaldehyde-fixed S. 
aureus and incubated for 1 h at 4°C. The immunoadsorbent was collected by centrifuga- 
tion, washed twice in HSB, twice with mixed detergent solution, and finally with PD. The 
pellets were suspended in Neville's SDS-PAGE running buffer (27) and boiled for 5 min 
and centrifuged at 10,000 g. 
SDS-PAGE.  SDS-PAGE was performed according to the method of Neville and Glass- 
man (27)  using 0.75-mm-thick slab  gels  with a  4-I I% polyacrylamide gradient in the 
running gel.  ~25I-containing lanes were dried and exposed at -70 ° on Kodak XR-5  X- 
omat film  using image intensification screens.  Apparent  molecular weights (Mr) were 
estimated by comparison with standard proteins (Bio-Rad Laboratories, Richmond, CA). 
Results 
Fc~2b/~lR  Expression  by LPS-activated  Spleen  Cells.  We have investigated the 
expression of FC72b/TIR by murine splenocytes after polyclonal activation by LPS 
or Con A  in  vitro for 4-6  d.  Compared  with untreated spleen cells or spleen 
cells incubated with Con A, treatment of spleen cells with LPS resulted  in an 
increase in the amount of cell-associated Fcv2b/71R measured by RIA in detergent 
lysates (Fig. 1A). The increase in total cell-associated FC~2b/-rl  R is reflected by the 
increased  number  of Fc~2b/~R  on  the  cell  surface  of LPSoactivated cells,  as 
detected by the binding of ~15I-2.4G2  (Fig.  1 and Table I).  In contrast, Con A 
had no effect of Fc-y2b/vlR expression (Fig.  1). 
The increase in cell-associated FC~2b/~lR was accompanied by the appearance 
in the culture supernatants of soluble material that was detected by the RIA (Fig. 
1B). The soluble factor must express the determinant recognized by the 2.4G2 
Fab as well as at least one additional determinant recognized by the rabbit anti- 
FC~2b/-¢l R antiserum, since the assay is dependent upon the immunoprecipitation 
by polyvalent rabbit anti-FCv2b/~lR  serum of 125I-2.4G2  Fab-antigen complexes, 
and the rabbit antiserum is adsorbed to remove any antibody reactive with 2.4G2 
Fab.  The  soluble  factor  is  thus antigenically related  to  Fc.r2b/~,lR  and  will  be 
referred to as soluble FCv2b/-r]R. 
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FIGURE  1.  LPS-induced  spleen cell-associated  and soluble F%~b/~IR. CD~F1 spleen cells were 
cultured at 5 x  105/ml in 75-cm 2 flasks for 5 d with no stimuli (open bars),  20 ttg/ml LPS 
(hatched bars), or 5 ttg/ml Con A (stippled bars). Cells and cell-free supernatants  were harvested 
at day 5 and cells were lysed in NP-40 at 1 ×  107 cell equivalents per milliliter. (A) Results of 
assaying 1 ×  105 cell equivalents  of cell lysates. (B) Radioimmunoassay  results obtained with 
i0 ttl of culture supernatant in a representative  experiment. 
TABLE  I 
Kinetics of LPS-induced Fc~2b/~l  R 
Cells 
FC~2b/-r!  R per cell (x 10  -4) 
Day  LPS  Cell surface  Soluble 
T-depleted spleen*  0  +  1.47  NA* 
1  +  0.95  ND  ! 
2  +  3.14  2.2 
3  +  2.03  2.3 
4  +  6.07  2.4 
6  +  17.3  47.0 
BCLI CW13.20  2  -  20.0  ND 
+  120.0  ND 
4  -  20.0  20.0 
+  32.4  145.0 
* CD2FI spleen  cells were depleted of 
described  in Materials and Methods. 
* Not applicable. 
0 Below the level of detectability. 
T  cells by anti-Thy-l.2 and C as 
centrifugation  at  100,000 g  for 90 min or by 100,000 g  centrifugation  followed 
by filtration  through a  0.45  ~tm  filter,  which resulted  in  88 and 83%  recovery, 
respectively (data not shown). These results  suggest that the soluble  F%2b/v~R is 
not associated with membrane  fragments. 
LPS-induced Fc,y2t~#ylR Is Associated with B Cells.  The cell population respond- 
ing to LPS with elevated  FCv2b/~lR expression was examined by depleting adher- 
ent cells and/or by killing T  cells with antibody and complement (C). T-depleted 
spleen  cells  responded  to  LPS  as  efficiently  as  whole  spleen  cell  cultures  with 
respect to synthesis of soluble and cell-associated  FC,~b/vlR (Table  II). Similarly, 
spleen  cells  depleted  of  adherent  cells  by  passage  through  G-10  Sephadex 
responded  to LPS by producing  increased  cell-associated  and soluble  FC,2b/vlR Exp. 
SOLUBLE  Fc  RECEPTORS 
TABLE  II 
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Culture supernatants 
(FcR/cell recovered, x 10  -4) 
Cell-associated FcR 
(FcR/cell recovered, x 10  -4) 
Untreated  T  depleted  Untreated  T  depleted 
None  LPS  None  LPS  None  LPS  None  LPS 
1  ND  0.82  0.16  0.96  NT  NT  NT  NT 
2  1.3  12.0  1.1  11.0  NT  NT  NT  NT 
3  0.7  7.2  0.5  4.8  NT  NT  NT  NT 
4  ND  1.3  ND  2.6  0.4  3.1  0.6  3.0 
5  ND  1.0  ND  0.7  0.1  5.5  2.2  20.0 
Con A  proliferative responses were inhibited >90% by anti-Thy-l.2 +  C  or by anti-Thy-1  +  anti- 
Lyt-I 4- anti-Lyt-2 followed by anti-rat-~" and C treatment. The number ofFeR per cell was calculated 
125  by comparing the amount of  1-2.4G2 Fab precipitated compared with a standard curve obtained 
with J774  or $49.1  cell lysates, assuming  10  ° and  105 receptors per J774 and $49.1,  respectively. 
The  limit of the radioimmunoassay is  2  x  l0  s  receptors per cell;  all samples below our  level of 
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FIGURE 2.  Effect of adherent cell depletion of the LPS-induced Fc,r~b/,iR response. Spleen 
cells were passed twice through Sephadex G-10 (hatched bars) and then cultured as in Fig.  1 
in parallel with untreated spleen cells (open bars). Cell lysates (A) (2.5 ×  10  4 cell equivalents) 
and culture supernatants (B) (5/zl) were assayed as in Fig.  1. 
(Fig. 2). Finally, we prepared enriched B cell populations by successive depletion 
of T  cells and adherent cells and found that neither T  cells nor adherent cells 
were required for this response (Fig.  3). To confirm this, we tested spleen cells 
depleted of B  cells  by panning on  anti-Ig-coated dishes followed by passage 
through a  nylon wool column. The B cell-depleted population  was unable to 
proliferate or secrete Ig in response to LPS (data not shown), and stimulation of 
these cells with LPS had no effect on  Fc.r2b/.ylR measured in cell lysates or cell- 
free supernatants (Fig. 4). 
We  have  obtained  similar  data  using  a  cloned  B  cell  tumor  line,  BCL~ 
CW13.20-3B3.  These cells respond to LPS, as do normal B cells, by differen- 
tiating into  IgM-secreting cells (24).  The  BCL1 cell line also responds to  LPS 
with increased surface Fc-r2b/-y1R and soluble FC~b/~]R (Table I). 
The increase in cell-associated Fc,2b/,lR on spleen cells stimulated with LPS 
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FIGURE  3.  Induction of Fc,2b/-tlR by LPS treatment of B cell-enriched spleen cells.  Spleen 
cells were depleted of T  cells and adherent cells as described above and the B cell population 
(hatched  bars) cultured as in  Fig.  1 in parallel with untreated  spleen cells (open  bars).  Cell 
lysates (5 x  10 4 cell equivalents) and culture supernatants (10 tzl) were assayed as in Fig. 1. 
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FIGURE 4.  Effect of B cell depletion on  LPS-induced  Fc~2b/~R expression. Splenic B cells 
were depleted by panning  on  RAMlg-coated dishes (solid bars)  or by panning  followed by 
passage through nylon wool (hatched bars) and were then cultured in parallel with untreated 
spleen cells (open bars) as described in Fig.  1.  1 ×  10 5 cell equivalents of the lysates or 5 tzl of 
culture supernatant were assayed for Fc~b/~jR by the monoclonal radioimmunoassay. 
(Table  I).  The  increase  in  cell  surface  FE3,2b/3,1R  was  apparent  by day  2  and 
continued to increase through day 5.  In contrast,  levels of soluble Fc~b/v~R did 
not significantly increase until day 4 or 5.  The cell viability ranged  from 65 to 
85%  throughout  these  experiments.  Similar  observations  were  made  for  the 
BCLI cell line, except that the kinetics were more rapid (Table I). On the second 
day after LPS stimulation, a sixfold increase in cell surface FC~2b/vlR  was observed 
but no soluble FC~2b/~lR was detected. Interestingly, at 4 d, the amount of surface 1842  SOLUBLE  Fc  RECEPTORS 
TABLE  III 
FcR in Pooled Mouse Serum 
Soluble FcR con- 
Strain  Sex  Preparation  centration (M-9)  * 
BALB/c  F  Unadsorbed  2.4 
2.4G2 Fab adsorbed*  ND 
Rat Fab adsorbed*  2.2 
B6AJ  F  Unadsorbed  2.0 
C3H/HeJ  F  Unadsorbed  1.7 
Plasma  1.5 
CB6FL  F  Unadsorbed  11.8 
CD~F1  M  Unadsorbed  7.0 
2.4G2 Fab adsorbed  ND 
Rat Fab adsorbed  6.6 
A/J  M 
Swiss  F 
Unadsorbed  1.0 
Unadsorbed  9.0 
2.4G2 Fab adsorbed  ND 
Rat Fab adsorbed  8.6 
Serum was prepared from at least five mice 2-4 mo old. 
* FcR concentration was calculated by determining the number ofJ774 
cell equivalents per sample and assuming  10  ~ receptors per J774  cell 
and an M, of 50,000 based on the Mr of purfied FcR from cell lysates. 
Not detectable (ND) indicates the sample contained undectable levels of 
FcR in 20 #1 (10 times the volume assayed for positive samples). 
* Serum was adsorbed by incubation with 2.4G2  Fab or normal rat Fab 
coupled to Sepharose 4B, each at 2 mg protein/ml Sepharose for 1 h at 
4°C. 
FcR declined compared with day 2, and the amount of soluble Fc-~2b/-rlR increased 
sevenfold in comparison with controls. The viability of the cell line was >90% in 
both control and LPS-stimulated cultures. 
In Vivo Analog of  Soluble Fc.r2b/.rlR.  The observation of FC~2b/vlR-cross-reactive 
material  in  the  cell-free  culture  supernatants  of  LPS-activated  splenocytes 
prompted  us  to  search  for  an  in  vivo equivalent  of this  molecule.  Serum  or 
plasma was prepared  from blood obtained from mice by cardiac puncture and 
was assayed for soluble Fc~2b/~lR by RIA. As shown in Table III, pooled serum 
and plasma from all strains tested contained soluble FC~2b/7~R at a  level of 10  -9 
to  10  -8 M.  This material  was quantitatively  removed by passage over a  2.4G2 
Fab-Sepharose column but not over a control rat Fab column (Table III). 
To assess if the level of FC72b/vlR in serum could be correlated with the state 
of activation of the immune system, we assayed serum from neonatal and germ- 
free mice. The quantity of soluble FCTzb/~lR in serum increased with the age of 
the animal (Table IV). The only adult mice that had low levels of soluble FCv2b  / 
v~R in  their  serum were germ-free animals  (Table IV). To further analyze the 
significance of circulating  Fc.r2b/vlR, we quantitated  soluble serum  Fc-/2b/.ylR in 
mice with  immunologic defects, including T  cell-deficient nude mice, autoim- PURE  ET  AL. 
TABLE  IV 
Serum FcR in Individual Germ-free Mice and Mice with Immune Defects 
1843 
Serum FcR 
Strain  Defect  n  Sex  Age  (M [X 10  -9] __. SEM) 
CDt  Control 
Germ-free 
BALB/c  nu/+ 
nu/nu 
MLR lpr/lpr  Autoimmune 
MRL/N  Autoimmune 
BXSB  Autoimmune 
NZB  Autoimmune 
NZB X NZW 
C57  lpr/lpr  Immunoproliferative 
C3H  lpr  Immunoproliferative 
C3H  Control 
C57  Control 
BALB/c  Control 
mo 
6  F  2.5  2.5 ±  0.5 
5  F  2.5  0.5 ±  0.08 
10  F  2.5  1.7±0.83 
10  F  2.5  3.0±0.23 
5  F  1  3.9 ±  1.2 
5  F  5  10.6 "4" 1.5 
5  F  1  0.9-_.  1.1 
5  F  5  5.2 -+ 1.5 
5  F  14  6.2 ±  1.6 
5  M  1  3.8 ±  0.8 
5  M  5  3.2 ±  0.5 
5  F  1  1.0 ±  0.8 
5  F  4  2.5 +  0.8 
5  F  1  0.8 ±  0.5 
5  F  10  3.3 ±  0.6 
5  F  1  3.0 ±  0.65 
5  F  7  1.8 ±  0.65 
5  F  1  4.7 ±  2.15 
5  F  10  6.6 ±  0.9 
5  M  1  2.8 ±  1.3 
5  M  10-14  5.8 ±  1.6 
5  F  1  0.76 ±  0.3 
5  F  10  2.4 ±  0.8 
5  F  1  1.6 ±  0.3 
5  F  7  4.2 ±  0.8 
5  F  2  6.4 ±  1.5 
5  F  7  6.3 ±  0.96 
5  F,M  1  2.6 ±  1 
5  F  7  6.4 ±  0.8 
* Serum was prepared from individual mice. 
* Concentration  of soluble  FCR  was determined  as 
standard error of the mean for each group. 
in  Table  III  and expressed as the average  ± 
mune mice (NZB and NZB ×  NZW),  and mice with autoimmune immunopro- 
liferative disorder (MRL lpr/lpr) (Table IV). BALB/c nude mice (BALB/c nu/ 
nu) were found to have levels of soluble Fc~2b/~lR comparable to that found in 
their  H-2,  sex-  and  age-matched controls  (BALB/c  nu/+).  Adult  mice  with 
autoimmune diseases were found to have levels of soluble Fc~b/~lR comparable 
to  that  found  in  their  H-2  sex-  and  age-matched controls.  However,  MRL, 
C57BL/6-congenic for the lpr gene of MRL,  and BXSB  mice, which display 1844  SOLUBLE  Fc  RECEPTORS 
TABLE  V 
lg-binding Activity of Serum Fc~2b/~R 
Fc,2b/~lR (J774 cell 
equivalents/ml [x 10-5]) 
Exp. 1  Exp. 2 
Unadsorbed  19.8  48.0 
Rabbit IgG-Sepharose  3.2  4.8 
Rabbit (  Fab')2-Sepharose  12.1  22.0 
BSA-Sepharose  NT  19.0 
Percent nonspecific adsorption*  39  54 
Percent specific adsorption*  74  78 
* Nonspecific adsorption  --  [100  -  (rabbit  (Fab')2-Sepharose)/(Unad- 
sorbed)]/X 100. 
* Specific adsorption --= [100 -  (rabbit lgG-Sepharose)/(rabbit (Fab')~- 
Sepharose)] x  100. 
marked hypergammaglobulinemias, have adult levels of serum FCv2b/sl  R at 1 mo, 
whereas normal  mice do not reach adult levels until  ~2  too.  Male BXSB mice 
show this high level of Fcs2b/slR at  1 mo but females do not.  The autoimmune 
disease of this strain is more prominent and appears earlier in males compared 
with females (28). 
Ig-binding  Activity  of Serum  FcR-like  Material.  To  determine  whether  the 
molecule(s) detected in serum that are antigenically related to Fcv2b/v~R are also 
functionally related  to the receptor we investigated the  Ig-binding  capacity of 
this material.  Mouse serum was adsorbed on normal  rabbit IgG or the F(ab')2 
fragment of rabbit IgG or BSA coupled to Sepharose 4B. The adsorbed serum 
was then tested in the RIA for Fc~b/s~R. As shown in Table V, 39-54% of the 
2.4G2-reactive material  was nonspecifically adsorbed to BSA-Sepharose or the 
F(ab')2 fragment of IgG. However, comparing the adsorption to the intact IgG- 
Sepharose with that adsorbed to the F(ab')2 fragment,  ~75% of the material was 
specifically bound to the intact IgG, demonstrating its binding activity for the Fc 
portion of Ig. 
Affinity  Purification  and  Characterization  of  Serum  Fc~2b/~lR-like  Mole- 
cules.  Mouse serum  (or rat serum as a  control),  was adsorbed to 2.4G2  Fab- 
Sepharose,  washed,  and  the  bound  protein  eluted  with  1  M  acetic  acid  as 
described in  Materials and  Methods.  The eluate was dialyzed, lyophilized, and 
then dissolved in PD. The mouse and rat proteins were radioiodinated in parallel 
and aliquots of each were then precleared with normal rabbit Ig-Sepharose and 
immunoprecipitated with rabbit anti-mouse Fc~2b/~lR (Fig. 5, B and C) or normal 
rabbit antiserum (Fig. 5, A and D) adsorbed to fixed S. aureus.  The immunopre- 
cipitates were subjected to electrophoresis on a  4-11% gradient SDS-polyacryl- 
amide gel and analyzed by autoradiography.  A polypeptide species of Mr 48,000 
was immunoprecipitated  from the affinity-purified mouse serum protein by the 
rabbit anti-Fc~2b/v~R (Fig.  5, B), whereas this  48,000 Mr protein  was absent in 
the normal rabbit serum control (Fig. 5, A). Furthermore, no 48,000 Mr protein 
was  immunoprecipitated  by  the  rabbit  anti-Fc~2b/~R  serum  from  rat  serum 
affinity-purified  on  2.4G2  Fab-Sepharose.  Rat  macrophages  lack  the  2.4G2 PURE  ET  AL.  1845 
FIGURE 5.  Immunoprecipitation of circulating Fc.r2b/vlR. 2.4G2 Fab affinity-purified mouse 
(A and B) or rat (C and D) serum proteins were precleared with normal rabbit sera adsorbed 
to S.  aureus.  The unadsorbed material was then immunoprecipitated with normal rabbit sera 
(A and D) or rabbit anti-FC,~b/,iR  sera (B and C) bound to S.  aureus.  The precipitates were 
collected by centrifugation and washed as described in Materials and Methods. The precipitates 
were then subjected to electrophoresis on a 4-I 1% SDS-polyacrylamide gel and analyzed by 
autoradiography.  The numbers indicated by arrows on the left represent the M, (xl0 -s) of 
standard  proteins run in parallel. The arrow at the right marks the 48,000 M, species that is 
specifically immunoprecipitated from the affinity-purified mouse serum proteins. 
determinant and rat serum does not react in the RIA for murine FCv2b/vlR (E. 
Pure, unpublished results). The dominant 23,000 Mr band precipitated by the 
rabbit anti-mouse FC,2b/~lR from both preparations (Fig.  5, B and C) is 2.4G2 
Fab stripped from the immunoadsorbent' column that reacts with anti-rat IgG 
reagents (data not shown). The  23,000  Mr material is the dominant iodinated 
species in the partially purified receptor, and the rabbit anti-FC,~b/,~R antiserum, 
despite adsorption, still immunoprecipitates some of this material. 
Discussion 
Polyclonal activation of murine splenocytes with  LPS  in  vitro  results  in  an 
increased  expression  of  Fc-r2b/~lR and  in  the  appearance  of a  soluble  non- 
membrane-associated molecule that is antigenically related to the FC~2b/~R. The 
increase in ceil-associated and soluble FC~2b/~lR after stimulation of spleen cells 
with LPS is attributable primarily to B cells. The kinetics of appearance of the 
soluble  FC~b/~lR,  in  both spleen cells and  BCLl  cells stimulated by LPS,  lags 
somewhat behind the increase in ceil-associated FC~2b/~lR. It is possible that Fc 
receptors may be synthesized in two distinct forms, one that is released as soluble 
protein and a  second anchored in the plasma membrane. Precedents for such 
soluble and membrane-bound alternatives exist for Ig (20, 30) and H-2 (31, 32) 
molecules in  which different exons encoding the carboxyl termini of the two 
forms  are  preferentially selected  during  RNA  processing.  Another  possible 
mechanism is that the soluble FC~2b/~lR and the membrane forms are products 
of closely related genes. Alternatively, the soluble form may be derived from the 
cell surface molecule by proteolysis. 
The in vivo analog of the soluble FC~2b/~l  R is probably the 2.4G2-cross-reactive 
material that we detect in mouse serum by RIA. Based on titrations of FC~2b/~R 
in cell lysates by RIA, we estimate that circulating FC~2b/~R is present at  1 × 
10 -9 to 1 ×  1-8 M in serum or plasma. Soluble FC~2b/~lR was present in the serum 
of all  male and  female mice ranging in age from  3  d  to  18  mo and  was  not 
restricted to any particular H-2 haplotype. That the quantity of FC~2b/~lR in T 1846  SOLUBLE  Fc  RECEPTORS 
cell-deficient nude  mice was  not  markedly different from that  found in  the 
normal controls supports our in vitro data that mature T  cells are not required 
for the production of soluble FC.r2b/.rIR. In agreement with Khayat et al. (33), we 
find the level of circulating FC~zb/~lR generally higher in adult compared with 
neonatal mice. Interestingly, the only adult mice that differed markedly in their 
level  of circulating  Fc~2b/~R  were  germ-free  mice,  which  had  very  low  or 
undetectable levels of Fcv2b/vlR in their serum compared with the sex- and age- 
matched controls. This suggests that expression of soluble FC~2b/~lR in normal 
mouse serum may also be modulated by activation of the immune system. 
The circulating FCv2b/~lR from serum that was affinity-purified on a  2.4G2 
Fab-immunoadsorbent column and immunoprecipitated with rabbit anti-Fc~zb/ 
~R  has an Mr of 48,000  in  SDS-PAGE,  and migrates in  gels as a  reasonably 
narrow species.  In  contrast,  the cell-associated receptor isolated by the  same 
method from BCL~ (E.  Pure,  unpublished results) or mouse macrophage cell 
lines (17) was considerably more diffuse, ranging from 47,000 to 68,000 Mr. A 
soluble  FcR has been isolated by affinity chromatography from metabolically 
labeled P388D~ cells by Loube and Dorrington (34). The purified protein was a 
clearly defined doublet in the Mr range 55,000-65,000.  The circulating form of 
the  Fc~zb/~lR described here is  intriguingly similar with respect to  molecular 
weight  to  the  lower  molecular weight  species  isolated  from  cells.  However, 
further biochemical studies are needed to clarify the relationships among the 
different molecules. 
The role of Fc receptors in the regulation of humoral immune responses and 
the  relationship  of soluble  Ig-binding  factors  (IBF)  to  membrane-bound  Fc 
receptors or the soluble FC~2b/~R-like material described is not yet clear, but 
the emerging theme is that IBF from T  cells regulate B cell Ig synthesis and that 
IBF may represent a  soluble form of T  cell Fc receptor. Both we and Khayat 
(33) have shown that the circulating FCv2b/~lR is capable of binding to IgG. Fc 
receptors specific for various Ig classes have been described on T  and B cells (5, 
10,  11,  16,  35-37). Indeed, it has been shown (14, 38) that T  cells bearing FcR 
regulate the synthesis of IgM and IgG antibodies, in part by secretion of soluble 
T  cell factors that bind IgG. Others have shown (13, 39) that T  cells bearing Fc 
receptors specific for IgG (FcR) regulate IgE antibody production via the release 
of T  cell factors having affinity for IgE.  Future studies will  therefore need to 
address the relation and function of B cell-derived soluble FC72b/.rlR and T  cell- 
derived IBF. 
Summary 
We have evaluated the expression of surface FCy2b/vlR by lipopolysaccharide 
(LPS)-activated murine spleen cells, the release of soluble Fc~2b/~R by activated 
spleen  cells,  and  the  presence of circulating  Fcv2b/~lR in  mouse serum.  LPS 
activation of murine spleen cells and a cloned B cell line, BCL-1 CW 13.20-3B3, 
resulted  in  a  5-10-fold  increase  in  surface  FC~2b/~R and  the  concominant 
appearance in  the culture medium of a  soluble  molecule that  is antigenically 
related to  the  Fc~2b/~lR. The  increase in  cell-associated and soluble  FC~2b/~R 
after LPS activation is attributable primarily to B cells. 
Circulating FCy2b/v~R was also detected in normal mouse serum at a concentra- PURE ET  AL.  1847 
tion of 10 -9 to  10 -8 M. Levels of circulating FCv2b/.rlR increased with the age of 
the animals, and were low in adult germ-free mice and elevated in young mice 
with  certain  autoimmune  diseases.  The  circulating  Fcs2b/v~R  bound  to  IgG- 
Sepharose, and was partially purified by affinity chromatography on 2.4G2 Fab- 
Sepharose.  After radiolabeling and immunoprecipitation with rabbit anti-FCv2b/ 
v~R serum, one component, of Mr 48,000, was detected. 
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